Editorial: what can be done when infliximab stops working in ulcerative colitis?
Aliment Pharmacol Ther
.
2016 Jan;43(1):164.
doi: 10.1111/apt.13422.
Authors
R K Boyapati
1
2
,
G T Ho
3
4
,
J Satsangi
3
Affiliations
1
Gastrointestinal Unit, Western General Hospital, Edinburgh, UK. ray.boyapati@ed.ac.uk.
2
MRC Centre for Inflammation Research, QMRI, Edinburgh, UK. ray.boyapati@ed.ac.uk.
3
Gastrointestinal Unit, Western General Hospital, Edinburgh, UK.
4
MRC Centre for Inflammation Research, QMRI, Edinburgh, UK.
PMID:
26638930
DOI:
10.1111/apt.13422
No abstract available
Publication types
Editorial
Comment
MeSH terms
Colitis, Ulcerative / drug therapy*
Female
Humans
Immunologic Factors / administration & dosage*
Infliximab / administration & dosage*
Male
Substances
Immunologic Factors
Infliximab
Grants and funding
G0800675/MRC_/Medical Research Council/United Kingdom
G0800759/MRC_/Medical Research Council/United Kingdom
ETM/137/CSO_/Chief Scientist Office/United Kingdom
ETM/75/CSO_/Chief Scientist Office/United Kingdom
G0701898/MRC_/Medical Research Council/United Kingdom
G0600329/MRC_/Medical Research Council/United Kingdom
G0901697/MRC_/Medical Research Council/United Kingdom